Acacia Research Corp., of Newport Beach, Calif., elected Louis Graziadio to its board.
Advanced Viral Research Corp., of Yonkers, N.Y., added Howard Young to its scientific advisory board.
Affymax Inc., of Palo Alto, Calif., elected Scott Greer to its board.
Amarin Corp. plc, of London, appointed Jonathan Lamb as general counsel and company secretary.
Amylin Pharmaceuticals Inc., of San Diego, elected James Wilson to its board.
Angiotech Pharmaceuticals Inc., of Vancouver, British Columbia, promoted David Hall to chief financial officer.
Ariad Pharmaceuticals Inc., of Cambridge, Mass., appointed Laurie Allen chief legal officer, senior vice president and corporate secretary.
Atrix Laboratories Inc., of Fort Collins, Colo., added Larry Tamura as director of regulatory affairs.
Avanir Pharmaceuticals Inc., of San Diego, added John Abrams to the scientific team of its subsidiary, Xenerex Biosciences.
Battelle Pulmonary Therapeutics Inc., of Columbus, Ohio, named Jim Donohue, James Allen, William Busse, Mitchell Friedman, Steve Rennard, Adam Wanner and Irwin Ziment to its advisory board.
BioMS Medical Corp., of Edmonton, Alberta, appointed Kjell Stenberg to its board.
Cellular Genomics Inc., of Branford, Conn., added Russell Allen as senior vice president of corporate development.
Ceregene Inc., of San Diego, added Dominick Vacante as senior director of product development and Brooks Ensign as director of business development.
Essential Therapeutics Inc., of Waltham, Mass., appointed Nancy Wetherbee vice president, business development.
Exelixis Inc., of South San Francisco, appointed Kimberly Manhard vice president, regulatory affairs; Harold Keer director, clinical research and development; and Annie Fong director, development.
Forward Ventures, of San Diego, added Stuart Collinson as partner.
Genaera Corp., of Plymouth Meeting, Pa., appointed David Jarosz executive vice president and chief business officer and promoted Kenneth Holroyd to executive vice president and chief operating officer.
GenVec Inc., of Gaithersburg, Md., promoted Henrik Rasmussen to senior vice president, clinical research and regulatory affairs; Bryan Butman to vice president, quality; Mary Sundeen to vice president, corporate communications; and Robert Tenerowicz to vice president, process development and clinical supplies.
GW Pharmaceuticals plc, of Wilts, UK, added Roger Pertwee as director of pharmacology.
ILEX Oncology Inc., of San Antonio, appointed Craig Tooman vice president of investor relations.
Immusol Inc., of San Diego, added Flossie Wong-Staal as chief scientific officer and vice president of genomics.
Memory Pharmaceuticals Corp., of Montvale, N.J., appointed James Barrett senior vice president, research and development, effective May 1.
NeoGenomics Inc., of Naples, Fla., named Navnit Mitter director of its cytogenetics, molecular biology and genetic research laboratory and said its CEO, Michael Dent, was selected to the steering committee for the Gulf Coast Life Sciences Initiative.
NuGEN Technologies Inc., of San Carlos, Calif., appointed David Lowe to its advisory board.